Torrent Pharmaceuticals Results Earnings Call for Q1FY25

Conference Call with Torrent Pharmaceuticals Management and Analysts on Q1FY25 Performance and Outlook. Listen to the full earnings transcript.
23-07-2024
Bigul

Torrent Pharma Q1FY25 results: Net profit up 21%, revenue rises 10%

Revenues in the USA market, however, were down by 12 per cent at Rs 259 crore, falling from Rs 293 crore reported in Q1 FY24
23-07-2024
Bigul

Q1FY25 Quarterly Result Announced for Torrent Pharmaceuticals Ltd.

Pharmaceuticals company Torrent Pharmaceuticals announced Q1FY25 results: Revenue at Rs 2,859 crore grew by 10% Gross Margin: 75.7%, Op. EBITDA margin at 31.6%, Growth: 14% Net Profit after tax at Rs 457 crore, up by 21% Other expenses include one-off expenses of Rs 20 crore (in international business) Adjusted for such one-off expenses, the underlying Op. EBITDA is Rs 924 crore and Op. EBITDA margin at 32.3% Result PDF
23-07-2024
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Results

Results Q1 FY 2024-25.
23-07-2024
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Post Quarterly Financial Result Conference call with investors / analyst
18-07-2024
Next Page
Close

Let's Open Free Demat Account